Skip to main content

Icosavax, Inc.

ICVXDelisted Feb 20, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001786255

Icosavax, Inc. was delisted on Feb 20, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 93 institutions reported holding it in 13F filings for Q4 2023, worth $663.0M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Icosavax, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ICVX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4253+11
Shares23.0M31.6M+8.54M (+37.1%)
Value$669.8M$716.1M+$46.3M (+6.9%)

New holders (13)

Institutions that held Icosavax, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ICVX in Q4 2021
InstitutionSharesValue% of portfolio
Qiming U.S. Ventures Management, LLC3,510,228$80.3M36.96%
NanoDimension, Inc.2,749,994$62.9M56.41%
Janus Henderson Group PLC1,846,660$40.8M0.02%
Swiss National Bank26,100$597.0K0.00%
Goldman Sachs Group Inc20,718$474.0K0.00%
State of Wisconsin Investment Board17,500$400.0K0.00%
DekaBank Deutsche Girozentrale13,000$296.0K0.00%
ProShare Advisors LLC8,767$201.0K0.00%
Allspring Global Investments Holdings, LLC6,074$138.0K0.00%
Brown, Lisle/Cummings, Inc.850$19.4K0.01%
Daiwa Securities Group Inc.114$3.00K0.00%
Captrust Financial Advisors139$3.00K0.00%
TCI Wealth Advisors, Inc.29$1.00K0.00%

Sold out (2)

Institutions that held Icosavax, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ICVX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Manufacturers Life Insurance Company, The7,387$219.0K
SG Americas Securities, LLC6,041$179.0K